Log In
Print
BCIQ
Print
Print this Print this
 

My5-FU (OnDose)

  Manage Alerts
Collapse Summary General Information
Company Saladax Biomedical Inc.
DescriptionNanoparticle-based immunoassay measuring 5-fluorouracil (5-FU) blood plasma levels
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetect 5-FU levels in blood plasma; Detect 5-FU levels in blood plasma of patients with colorectal cancer
Regulatory Designation

Partner

Shanghai Fosun Pharmaceutical Group Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today